Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen.

Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen.

In the absence of strategies for reliable induction of antibodies broadly neutralizing human immunodeficiency virus type 1 (HIV-1), vaccine efforts have shifted toward the induction of cell-mediated immunity. Here we describe the construction and immunogenicity of novel T-cell vaccine NS1.HIVA, whic...

書誌詳細
主要な著者:	Larke, N, Murphy, A, Wirblich, C, Teoh, D, Estcourt, M, Mcmichael, A, Roy, P, Hanke, T
フォーマット:	Journal article
言語:	English
出版事項:	2005

類似資料

Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
著者:: Hanke, T, 等
出版事項: (1999)

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.
著者:: Allen, T, 等
出版事項: (2000)

Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine.
著者:: Hanke, T, 等
出版事項: (2003)

Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.
著者:: Sharpe, S, 等
出版事項: (2003)

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.
著者:: Hanke, T, 等
出版事項: (2007)

DNA vaccines against human immunodeficiency virus type 1.
著者:: Estcourt, M, 等
出版事項: (2004)

T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load.
著者:: Roshorm, Y, 等
出版事項: (2012)

The atomic structure of the bluetongue virus core.
著者:: Grimes, J, 等
出版事項: (1998)

Bluetongue virus: the role of synchrotron radiation
著者:: Diprose, J, 等
出版事項: (1999)

The atomic structure of bluetongue virus core
著者:: Grimes, J, 等
出版事項: (1999)

Therapeutic vaccination against hepatitis B virus using heterolgous prime boost strategy with DNA and modified vaccinia virus ankara vectors
著者:: McConkey, S, 等
出版事項: (2003)

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes.
著者:: Goonetilleke, N, 等
出版事項: (2006)

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
著者:: McShane, H, 等
出版事項: (2004)

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.
著者:: Dorrell, L, 等
出版事項: (2006)

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers.
著者:: Cebere, I, 等
出版事項: (2006)

A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.
著者:: Schneider, J, 等
出版事項: (2001)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
著者:: Mcshane, H, 等
出版事項: (2001)

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
著者:: Hanke, T, 等
出版事項: (1998)

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
著者:: McConkey, S, 等
出版事項: (2003)

Bluetongue virus replication, molecular and structural biology.
著者:: Mertens, P, 等
出版事項: (2004)

The crystal structure of bluetongue virus VP7.
著者:: Grimes, J, 等
出版事項: (1995)

Current techniques in rapid bluetongue virus diagnosis.
著者:: Gould, A, 等
出版事項: (1989)

Altered primary CD8+ T cell response to a modified virus Ankara(MVA)-vectored vaccine in the absence of CD4+ T cell help.
著者:: Estcourt, M, 等
出版事項: (2005)

Cytotoxic T-cell response to simian immunodeficiency virus by cynomolgus macaque monkeys immunized with recombinant vaccinia virus.
著者:: Gotch, F, 等
出版事項: (1991)

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
著者:: Dorrell, L, 等
出版事項: (2000)

The core of bluetongue virus binds double-stranded RNA.
著者:: Diprose, J, 等
出版事項: (2002)

Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
著者:: Tchilian, E, 等
出版事項: (2009)

Erratum: Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction (Journal of General Virology (2007) vol. 88 ( 1) (1-12))
著者:: Hanke, T, 等
出版事項: (2008)

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.
著者:: Mwau, M, 等
出版事項: (2004)

Erratum: Immunogenicity and protective efficacy of prime-boost regimens with recombinant δureC hly+ Mycobacterium bovis BCG and modified Vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis
著者:: Tchilian, E, 等
出版事項: (2011)

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity.
著者:: Sharpe, S, 等
出版事項: (2001)

Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.
著者:: Walther, M, 等
出版事項: (2006)

Bluetongue virus VP4 is an RNA-capping assembly line.
著者:: Sutton, G, 等
出版事項: (2007)

The bluetongue virus core: a nano-scale transcription machine.
著者:: Mertens, P, 等
出版事項: (2004)

Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal
著者:: Venkatraman, N, 等
出版事項: (2018)

Human Immunodeficiency Virus
著者:: Gupta, R, 等
出版事項: (2009)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
著者:: Rosario, M, 等
出版事項: (2010)

Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaques.
著者:: Rosario, M, 等
出版事項: (2010)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
著者:: Schneider, J, 等
出版事項: (1998)

Human and simian immunodeficiency viruses: virus-receptor interactions.
著者:: Signoret, N, 等
出版事項: (1993)